Cervix Cancer Clinical Trials in Dallas, Texas
2 recruitingDallas, Texas
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
Cervical CancerCervix Cancer
University of Texas Southwestern Medical Center30 enrolled1 locationNCT06266338
Recruiting
Phase 1
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple-Negative Breast CancerHead and Neck Squamous Cell CarcinomaMetastatic Cancer+11 more
OncoNano Medicine, Inc.168 enrolled16 locationsNCT06022029